Number of risk genotypes is a risk factor for major depressive disorder: A case control study

Behavioral and Brain Functions

Volumn 2, Issue , 2006, Pages

  Garriock, Holly A ^a,b   Delgado, Pedro ^c   Kling, Mitchel A ^d   Carpenter, Linda L ^e   Burke, Michael ^f   Burke, William J ^g   Schwartz, Thomas ^h   Marangell, Lauren B ⁱ   Husain, Mustafa ^j   Erickson, Robert P ^a   Moreno, Francisco A ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e BUTLER HOSPITAL   (United States)

^f UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^g UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^h Department of Psychiatry   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; EXON; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VARIABLE NUMBER OF TANDEM REPEAT; X CHROMOSOME LINKAGE;

EID: 33746933267     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-2-24     Document Type: Article

References (24)

1. Merikangas KR, Prusoff BA, Weissman MM: Parental concordance for affective disorders: Psychopathology in offspring. J Affect Disord 1988, 15:279-290.
2. Winokur G, Tsuang MT, Crowe RR: The Iowa 500: Affective disorder in relatives of manic and depressed patients. Am J Psychiatry 1982, 139:209-212.
3. Gershon ES, Hamovit J, Guroff JJ, Dibble E, Leckman JF, Sceery W, Targum SD, Nurnberger JIJ, Goldin LR, Bunney WEJ: A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry 1982, 39:1157-1167.
4. Weissman MM, Gershon ES, Kidd KK, Prusoff BA, Leckman JF, Dibble E, Hamovit J, Thompson WD, Pauls DL, Guroff JJ: Psychiatric disorders in the relatives of probands with affective disorders. The Yale University-National Institute of Mental Health Collaborative Study. Arch Gen Psychiatry 1984, 41:13-21.
5. Kutcher S, Marton P: Affective disorders in first-degree relatives of adolescent onset bipolars, unipolars, and normal controls. J Am Acad Child Adolesc Psychiatry 1991, 30:75-78.
6. Bland RC, Newman SC, Orn H: Recurrent and nonrecurrent depression. A family study. Arch Gen Psychiatry 1986, 43:1085-1089.
7. Warner V, Mufson L, Weissman MM: Offspring at high and low risk for depression and anxiety: Mechanisms of psychiatric disorder. J Am Acad Child Adolesc Psychiatry 1995, 34:786-797.
8. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R: Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
9. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B: The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: A replication. Arch Gen Psychiatry 2005, 62:529-535.
10. Thase ME RAJ: Treatment-Resistant Depression. In Psychopharmocology; The Fourth Generation of Progress Volume 92. 4th edition. Edited by. Bloom FE KDJ. New York Raven Press; 1995:1081-1097.
11. Crown WH, Finkelstein S, Berndt ER, Ling D, Poret AW, Rush AJ, Russell JM: The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry 2002, 63:963-971.
12. Baumann P, Broly F, Kosel M, Eap CB: Ultrarapid metabolism of clomipramine in a therapy-resistant depressive patient, as confirmed by CYP2 D6 genotyping. Pharmacopsychiatry 1998, 31:72.
13. Association AP: Diagnostic and Statistical Manual of Mental Disorders IV Arlington, VA, American Psychiatric Association; 2000.
14. Oquendo MA, Malone KM, Ellis SP, Sackeim HA, Mann JJ: Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior. Am J Psychiatry 1999, 156:190-194.
15. Prudic J, Sackeim HA, Devanand DP: Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 1990, 31:287-296.
16. Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, Greenberg R, Rifas SL, Sackeim HA. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 1996, 153:985-992.
17. Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S: The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990, 10:96-104.
18. Sackeim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z, Johnson CK Seidman S, Giller C, Haines S, Simpson RKJ, Goodman RR: Vagus nerve stimulation (VNS) for treatment-resistant depression: Efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001, 25:713-728.
19. Sackeim HA, Keilp JG, Rush AJ, George MS, Marangell LB, Dormer JS, Burt T, Lisanby SH, Husain M, Cullum CM, Oliver N, Zboyan H: The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry Neuropsychol Behav Neurol 2001, 14:53-62.
20. Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, Fitzsimons L, Moody BJ, Clark J: A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000, 57:425-434.
21. George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM, Howland R, Kling MA, Moreno F, Rittberg B, Dunner D, Schwartz T, Carpenter L, Burke M, Ninan P, Goodnick P: A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 2005, 58:364-373.
22. Mazure C, Nelson JC, Price LH: Reliability and validity of the symptoms of major depressive illness. Arch Gen Psychiatry 1986, 43:451-456.
23. Spitzer RL, Williams JB, Gibbon M, First MB: The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 1992, 49:624-629.
24. Storey JD, Tibshirani R: Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003, 100:9440-9445.